Quote For Affymetrix, Inc. AFFX.O
sector: Healthcare ·
industry: Biotechnology ·
$4.75
2 Dec 2009
+0.64%
$4.75
--
1,059,268
$4.76
$4.66
$10.06
$1.78
2.29
1,151,977
News
Press Releases
Key Developments
Officers
| Name |
Current Position |
Compensation |
| Fodor, Stephen |
Executive Chairman of the Board |
1,585,820 |
| King, Kevin |
President, Chief Executive Officer, Director |
1,514,390 |
| Batty, John |
Chief Financial Officer, Executive Vice President |
683,256 |
Key Ratios and Statistics
| Share Related Items |
| Market Cap (Mil.) |
$335.43 |
| Shares Outstanding (Mil.) |
70.62 |
| Float (Mil.) |
69.80 |
| |
| Dividend Information |
| Yield % |
-99,999.99 |
| Annual Dividend ($ USD) |
0.00 |
| Payout Ratio(TTM) % |
-- |
| |
| Financial Strength |
| Quick Ratio |
5.69 |
| Current Ratio |
6.11 |
| LT Debt/Equity |
85.47 |
| Total Debt/Equity |
85.47 |
| |
| Valuation Ratios |
| Price/Earnings(TTM) |
-- |
| Price/Sales(TTM) |
1.06 |
| Price/Book(TTM) |
1.16 |
| Price/Cash Flow(TTM) |
-- |
| |
|
| Per Share Data |
| Earnings(TTM) |
$-5.04 |
| Sales(TTM) |
$4.61 |
| Book Value(MRQ) |
$4.10 |
| Cash Flow(TTM) |
$-- |
| Cash(MRQ) |
$4.01 |
|
| Management Effectiveness |
| Return on Equity(TTM) |
-74.73 |
| Return on Assets(TTM) |
-38.92 |
| Return on Investment(TTM) |
-42.23 |
| |
|
| Margins |
| Gross Margin(TTM) % |
48.32 |
| Operating Margin(TTM) % |
-93.54 |
| Profit Margin(TTM) % |
-109.01 |
|
| |
|
UK
US
- Europe
- Asia
- UK Most Actives